Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
Notes - Segment information, etc.
Notes - Segment information, etc.
Description of impairment losses not allocated to reportable segments
(注)海外事業の減損損失は、連結損益計算書上、子会社化関連損益に含めて表示しております。

Talk to a Data Expert

Have a question? We'll get back to you promptly.